Johnson & Johnson launched the Virtuguide System, an AI-powered, patient-matched solution designed to support Lapidus procedures, a type of bunion surgery that helps realign the foot by joining two bones near the arch. The system uses pre-operative planning software, developed in collaboration with PeekMed, to assess each patient’s bunion and make personalized recommendations for the intended correction and reduce surgical complexity. This launch follows the 510(k) clearance from the FDA for the Pre-operative Planning Software, granted earlier this year.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
- How Johnson & Johnson Stock (JNJ) Discovered a New Lease on Life
- Pacira upgraded to Buy from Hold at Truist
- Johnson & Johnson management to meet with Oppenheimer
- Halozyme says EU approves new indication for Janssen’s Darzalex Faspro